FOX Business Novo Nordisk executive reports high interest for once-daily, oral weight-loss pill
Novo Nordisk executive Dave Moore touted high interest in Wegovy's oral version of its injectable GLP-1 weight-loss medication on FOX Business, saying there's "a lot of excitement."